Doxycycline NDC 70518-0213

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-0213Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-0213Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70518-0213-0	70518021300	30 CAPSULE in 1 BLISTER PACK (70518-0213-0)Marketed from Feb 10, 2017
70518-0213-1	70518021301	20 CAPSULE in 1 BLISTER PACK (70518-0213-1)Marketed from Feb 10, 2017
70518-0213-2	70518021302	14 CAPSULE in 1 BOTTLE, PLASTIC (70518-0213-2)Marketed from May 31, 2017
70518-0213-3	70518021303	20 CAPSULE in 1 BOTTLE, PLASTIC (70518-0213-3)Marketed from Jul 17, 2017
70518-0213-7	70518021307	14 CAPSULE in 1 BLISTER PACK (70518-0213-7)Marketed from Mar 17, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204234
Marketing start: Feb 10, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 70518-0213_55015b68-494f-f50c-e063-6394a90a6137SPL ID 55015b68-494f-f50c-e063-6394a90a6137SPL set ID fa2d9328-b688-47af-8c4d-dc328cf35392RxCUI 1649990UNII N12000U13O
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518021300 followed by a unit qualifier and the quantity

Package 70518-0213-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 24, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky Mountain spotted fever, typhus fever and the typhus gro…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204234

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204234
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline	Doxycycline 100 mg/1	CapsuleOral	Proficient Rx LP	63187-672
Doxycycline	Doxycycline 50 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-650
Doxycycline	Doxycycline 100 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-652
Doxycycline	Doxycycline 100 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-711